METHODS: This cross-sectional study included 505 cancer patients from mainland China. In addition to sociodemographic and clinical characteristics, the CERQ-short and the distress thermometer were included in the study measures.
RESULTS: Item analysis indicated a promising result. And the results of CFA indicated that the CERQ-short demonstrated satisfactory factorial validity in cancer patients. Cronbach\'s alpha coefficients were between 0.663 and 0.910, while McDonald\'s omega coefficients were between 0.664 and 0.910. The CERQ-short had sufficient convergent, discriminant and concurrent validity among cancer patients. Lastly, MI supported that the CERQ-short demonstrated strong measurement equivalence across gender, residence and age.
CONCLUSIONS: This study shows that the Chinese version of the CERQ-short has convincing psychometric properties and MI, which supports its use in cancer patients.
方法:这项横断面研究包括来自中国大陆的505名癌症患者。除了社会人口统计学和临床特征,CERQ-short和遇险温度计被纳入研究测量.
结果:项目分析显示有希望的结果。CFA的结果表明,CERQ-short在癌症患者中显示出令人满意的因子效度。Cronbach的α系数在0.663和0.910之间,而McDonald的ω系数在0.664和0.910之间。CERQ-short具有足够的收敛性,癌症患者的判别效度和并行效度。最后,MI支持CERQ-short在性别上表现出强烈的测量等效性,居住和年龄。
结论:这项研究表明,CERQ-short的中文版具有令人信服的心理测量特性和MI,这支持它在癌症患者中的使用。